Article
Delights and let-downs in the management of tumor necrosis factor receptor-associated periodic syndrome: the canakinumab experience in a patient with a high-penetrance T50M TNFRSF1A variant.
International journal of rheumatic diseases - 1 May 2015
Cantarini Luca, Lopalco Giuseppe, Vitale Antonio, Caso Francesco, Lapadula Giovanni, Iannone Florenzo, Galeazzi Mauro, Rigante Donato
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.